Sublingual immunotherapy for canine atopic dermatitis

Canine atopic dermatitis is a common diagnosis, affecting as much as 3-10% of the canine population. Allergen-specific immunotherapy (ASIT) via subcutaneous injection – “allergy shots” – has efficacy in as many as 70% of treated patients; however, it requires weekly to twice-monthly injections. Owners who find injections difficult to administer, or who are frightened of needles, can turn to sublingual immunotherapy (SLIT).

---